Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-02-28

Clinical Trial Update: Combination Chemotherapy and Bevacizumab in Treating Patients With Stage IV Colorectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating combination chemotherapy with Bevacizumab in stage IV colorectal cancer; the study was terminated and results were posted in 201…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bevacizumab (Avastin) (bevacizumab)

Snippet

Sponsor: University of Miami | Conditions: Colorectal Cancer | Phase 2 | Status: TERMINATED | Results posted: 2013-02-28